(1987) at Yale University unprecedently demonstrated that phlorizin completely normalized insulin sensitivity in diabetic rats without hypoglycemia—was a connection made between SGLT2 inhibitors and the treatment of diabetes. The gene discussed is SLC5A2; the disease is diabetes mellitus.